RA CAPITAL MANAGEMENT, L.P.
Q1 2022 13F-HR Holdings
Net value change ($000)
-1,088,793
(-19.2%)
New positions
10
Sold out positions
11
Turnover %
17.1%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2021
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| BIIB | 153,111 | NEW |
| ENTA | 68,633 | NEW |
| ANTX | 55,257 | NEW |
| JBIO | 54,047 | 55.5% |
| NTRA | 53,303 | NEW |
| VERA | 46,183 | NEW |
| GH | 31,555 | NEW |
| ACRS | 31,339 | NEW |
| RNAM | 29,963 | 297.6% |
| ChemoCentryx, Inc. | 28,980 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| NVAX | -249,107 | -83.0% |
| ASND | -129,941 | -12.8% |
| Icosavax, Inc. | -90,248 | -68.3% |
| iTeos Therapeutics, Inc. | -63,521 | -30.9% |
| VOR | -62,055 | -48.0% |
| PHAT | -61,272 | -100.0% |
| ZOGENIX, INC. | -54,173 | -100.0% |
| TVTX | -47,408 | -27.2% |
| JANX | -46,735 | -27.3% |
| ImmunoGen, Inc. | -46,703 | -31.1% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|